Low plasma exosomal circLPAR1 was found to be significantly linked with tumor size, differentiation level, TNM staging, vascular invasion, lymphatic metastasis, and HER2 expression in GC patients (p < 0.05) [63]. The gene discussed is ERBB2; the disease is neoplasm.